Cortexyme Inc
Change company Symbol lookup
Select an option...
CRTX Cortexyme Inc
SSSS SuRo Capital Corp
AVD American Vanguard Corp
VMVFX Vanguard Global Minimum Volatility Fund Investor Shares
IO ION Geophysical Corp
DNRCQ Denbury Resources Inc
MSFT Microsoft Corp
BCRX BioCryst Pharmaceuticals Inc
WMT WALMART STORES INC
ZN Zion Oil and Gas Inc
Go

Health Care : Biotechnology |
Company profile

Cortexyme, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on providing disease-modifying therapeutics to treat Alzheimer’s and other degenerative diseases. The Company is focused on a infectious pathogen tied to neurodegeneration in humans and animal models. The Company’s lead drug candidate, COR388, is an orally-administered, brain-penetrating small molecule gingipain inhibitor designed for the treatment of Alzheimer’s disease. COR388 is designed to target an upstream driver of multiple Alzheimer’s pathological pathways, including amyloid beta production, inflammation and neurodegeneration, in contrast to mechanisms of action targeting downstream effects, such as amyloid plaques and tau tangles.

Price
Delayed
$44.70
Day's Change
-0.42 (-0.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
45.36
Day's Low
44.02
Volume
(Light)

Today's volume of 2,668 shares is on pace to be much lighter than CRTX's 10-day average volume of 63,562 shares.

2,668
  • Prev Close
    45.12
  • Today's Open
    44.88
  • Day's Range
    44.02-45.36
  • Avg Vol (10-day)
    63.6K
  • Last (time)
    10:34a ET 08/14/20
  • Last (size)
    100
  • 52-Wk Range
    19.35 - 73.84
    LowHigh
  • (08/30/19 - 02/14/20)
    131.01%
  • 100.7%
  • Market Cap
    1.3B
  • Shares Outstanding
    29.4M
  • -1.73
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 39.13
  • (% of float 07/31/20)
    9.29

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.